BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 22939358)

  • 1. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.
    Bakris GL; Sica D; White WB; Cushman WC; Weber MA; Handley A; Song E; Kupfer S
    Am J Med; 2012 Dec; 125(12):1229.e1-1229.e10. PubMed ID: 22939358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension.
    Cushman WC; Bakris GL; White WB; Weber MA; Sica D; Roberts A; Lloyd E; Kupfer S
    Hypertension; 2012 Aug; 60(2):310-8. PubMed ID: 22710649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azilsartan medoxomil/chlorthalidone: a new fixed-dose combination antihypertensive.
    Pierini D; Anderson KV
    Ann Pharmacother; 2013 May; 47(5):694-703. PubMed ID: 23585646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension.
    White WB; Weber MA; Sica D; Bakris GL; Perez A; Cao C; Kupfer S
    Hypertension; 2011 Mar; 57(3):413-20. PubMed ID: 21282560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide.
    Neutel JM; Cushman WC; Lloyd E; Barger B; Handley A
    J Clin Hypertens (Greenwich); 2017 Sep; 19(9):874-883. PubMed ID: 28681550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?
    Barrios V; Escobar C
    Expert Opin Pharmacother; 2013 Nov; 14(16):2249-61. PubMed ID: 24070321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone.
    Weber MA; Sever P; Juhasz A; Roberts A; Cao C
    J Renin Angiotensin Aldosterone Syst; 2018; 19(3):1470320318795000. PubMed ID: 30175930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.
    Zhu DL; Bays H; Gao P; Mattheus M; Voelker B; Ruilope LM
    Clin Ther; 2012 Jul; 34(7):1613-24. PubMed ID: 22717420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension.
    Cushman WC; Bakris GL; White WB; Weber MA; Sica D; Roberts A; Lloyd E; Kupfer S
    J Hypertens; 2018 Apr; 36(4):947-956. PubMed ID: 29334491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azilsartan medoxomil: a new Angiotensin receptor blocker.
    Zaiken K; Cheng JW
    Clin Ther; 2011 Nov; 33(11):1577-89. PubMed ID: 22071238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study.
    Sica D; Bakris GL; White WB; Weber MA; Cushman WC; Huang P; Roberts A; Kupfer S
    J Clin Hypertens (Greenwich); 2012 May; 14(5):284-92. PubMed ID: 22533654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of azilsartan medoxomil/chlortalidone fixed-dose combination in hypertensive patients uncontrolled on azilsartan medoxomil alone: A randomized trial.
    Collier DJ; Juhasz A; Agabiti-Rosei E; Lloyd E; Hisada M; Zhao L; Kupfer S; Caulfield MJ
    J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1473-1484. PubMed ID: 30302936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability, and efficacy of azilsartan medoxomil with or without chlorthalidone during and after 8 months of treatment for hypertension.
    Kipnes MS; Handley A; Lloyd E; Barger B; Roberts A
    J Clin Hypertens (Greenwich); 2015 Mar; 17(3):183-92. PubMed ID: 25619410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-pill Combination Therapy of Azilsartan Medoxomil/Chlorthalidone for Treatment of Hypertension: A Systematic Review.
    Kwon A; Kim GH
    Clin Ther; 2020 Jul; 42(7):1390-1403. PubMed ID: 32595000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of azilsartan medoxomil with chlorthalidone in hypertension.
    Baker WL; Nigro SC; White WB
    Expert Rev Cardiovasc Ther; 2014 Jul; 12(7):791-8. PubMed ID: 24881461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antihypertensive Efficacy of Fixed Combination Azilsartan Medoxomil / Chlorthalidone in Patients With Uncontrolled Arterial Hypertension].
    Kobalava ZD; Villevalde SV; Kulakov VV
    Kardiologiia; 2017 Nov; 57(11):12-18. PubMed ID: 29276912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olmesartan medoxomil combined with hydrochlorothiazide improves 24-hour blood pressure control in moderate-to-severe hypertension.
    Rosenbaum D; Girerd X
    Curr Med Res Opin; 2012 Feb; 28(2):179-86. PubMed ID: 22114906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.